Shokeir Ahmed A
Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
J Urol. 2007 Nov;178(5):1860-6. doi: 10.1016/j.juro.2007.07.008. Epub 2007 Sep 17.
A review of the existing literature showed that the subject of live donor nephrectomy is a seat of underreporting and underestimation of complications. We provide a systematic comparison between laparoscopic and open live donor nephrectomy with special emphasis on the safety of donors and grafts.
The PubMed literature database was searched from inception to October 2006. A comparison was made between laparoscopic and open live donor nephrectomy regarding donor safety and graft efficacy.
The review included 69 studies. There were 7 randomized controlled trials, 5 prospective nonrandomized studies, 22 retrospective controlled studies, 26 large (greater than 100 donors), retrospective, noncontrolled studies, 8 case reports and 1 experimental study. Most investigators concluded that, compared to open live donor nephrectomy, laparoscopic live donor nephrectomy provides equal graft function, an equal rejection rate, equal urological complications, and equal patient and graft survival. Analgesic requirements, pain data, hospital stay and time to return to work are significantly in favor of the laparoscopic procedure. On the other hand, laparoscopic live donor nephrectomy has the disadvantages of increased operative time, increased warm ischemia time and increased major complications requiring reoperation. In terms of donor safety at least 8 perioperative deaths were recorded after laparoscopic live donor nephrectomy. These perioperative deaths were not documented in recent review articles. Ten perioperative deaths were reported with open live donor nephrectomy by 1991. No perioperative mortalities have been recorded following open live donor nephrectomy since 1991. Regarding graft safety, at least 15 graft losses directly related to the surgical technique of laparoscopic live donor nephrectomy were found but none was emphasized in recent review articles. The incidence of graft loss due to technical reasons in the early reports of open live donor nephrectomy was not properly documented in the literature.
We are in need of a live organ donor registry to determine the combined experience of complications and long-term outcomes, rather than short-term reports from single institutions. Like all other new techniques, laparoscopic live donor nephrectomy should be developed and improved at a few centers of excellence to avoid the loss of a donor or a graft.
对现有文献的回顾显示,活体供肾切除术的相关主题存在并发症报告不足和估计不足的情况。我们对腹腔镜活体供肾切除术和开放活体供肾切除术进行了系统比较,特别强调供体和移植物的安全性。
检索了自数据库建立至2006年10月的PubMed文献数据库。对腹腔镜活体供肾切除术和开放活体供肾切除术在供体安全性和移植物效能方面进行了比较。
该综述纳入了69项研究。其中有7项随机对照试验、5项前瞻性非随机研究、22项回顾性对照研究、26项大型(超过100例供体)回顾性非对照研究、8例病例报告和1项实验研究。大多数研究者得出结论,与开放活体供肾切除术相比,腹腔镜活体供肾切除术能提供同等的移植物功能、同等的排斥率、同等的泌尿系统并发症以及同等的患者和移植物存活率。镇痛需求、疼痛数据、住院时间和恢复工作时间明显有利于腹腔镜手术。另一方面,腹腔镜活体供肾切除术存在手术时间延长、热缺血时间延长以及需要再次手术的严重并发症增加等缺点。在供体安全性方面,腹腔镜活体供肾切除术后至少记录了8例围手术期死亡。这些围手术期死亡在近期的综述文章中未被记录。1991年报告开放活体供肾切除术后有10例围手术期死亡。自那以后,开放活体供肾切除术后未记录到围手术期死亡病例。关于移植物安全性,发现至少有15例移植物丢失与腹腔镜活体供肾切除术的手术技术直接相关,但近期的综述文章中均未强调。开放活体供肾切除术早期报告中因技术原因导致的移植物丢失发生率在文献中记录不确切。
我们需要一个活体器官供体登记系统来确定并发症和长期结果的综合经验,而不是单个机构的短期报告。与所有其他新技术一样,腹腔镜活体供肾切除术应在少数几个卓越中心进行开发和改进,以避免供体或移植物的损失。